- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/062 - Dipeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
Patent holdings for IPC class C07K 5/062
Total number of patents in this class: 876
10-year publication summary
|
75
|
78
|
73
|
52
|
65
|
40
|
54
|
59
|
58
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biohaven Therapeutics Ltd. | 113 |
14 |
| Albireo AB | 175 |
13 |
| Bristol-myers Squibb Company | 4797 |
12 |
| Dana-Farber Cancer Institute, Inc. | 2619 |
11 |
| Nissan Chemical Industries, Ltd. | 1696 |
11 |
| Allergan, Inc. | 2309 |
10 |
| Cornell University | 3366 |
9 |
| MedImmune Limited | 623 |
9 |
| Arvinas Operations, Inc. | 242 |
9 |
| Case Western Reserve University | 1852 |
8 |
| ImmunoGen, Inc. | 401 |
8 |
| Hoffmann-La Roche Inc. | 3555 |
7 |
| Siemens Medical Solutions USA, Inc. | 1497 |
7 |
| Helsinn Healthcare SA | 229 |
7 |
| Medivir AB | 118 |
7 |
| On Target Laboratories, LLC | 32 |
7 |
| Ono Pharmaceutical Co., Ltd. | 424 |
7 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 315 |
7 |
| Evonik Operations GmbH | 4168 |
7 |
| The Board of Trustees of the Leland Stanford Junior University | 6545 |
6 |
| Other owners | 700 |